{"id":"https://openalex.org/W7225160844","doi":"https://doi.org/10.1111/cts.70751","title":"Phase 1 Evaluation of the Pharmacokinetics of Sevasemten ( EDG \u20105506) for Potential Food Effect and Drug\u2013Drug Interaction With a CYP3A4 Moderate Inhibitor","display_name":"Phase 1 Evaluation of the Pharmacokinetics of Sevasemten ( EDG \u20105506) for Potential Food Effect and Drug\u2013Drug Interaction With a CYP3A4 Moderate Inhibitor","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225160844","doi":"https://doi.org/10.1111/cts.70751","pmid":"https://pubmed.ncbi.nlm.nih.gov/42974700","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13729000"},"language":"en","primary_location":{"id":"doi:10.1111/cts.70751","doi":"https://doi.org/10.1111/cts.70751","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.70751","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70751","source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70751","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018840484","display_name":"Molly C. Madden","orcid":"https://orcid.org/0009-0009-9008-7288","observed_orcids":["https://orcid.org/0009-0009-9008-7288"]},"institutions":[{"id":"https://openalex.org/I4387153259","display_name":"Edgewise Therapeutics (United States)","ror":"https://ror.org/03phcd550","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Molly Madden","raw_affiliation_strings":["Edgewise Therapeutics, Inc.  Boulder Colorado USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Edgewise Therapeutics, Inc.  Boulder Colorado USA","institution_ids":["https://openalex.org/I4387153259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070311552","display_name":"Roxana Donisa Dreghici","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153259","display_name":"Edgewise Therapeutics (United States)","ror":"https://ror.org/03phcd550","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roxana Donisa Dreghici","raw_affiliation_strings":["Edgewise Therapeutics, Inc.  Boulder Colorado USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Edgewise Therapeutics, Inc.  Boulder Colorado USA","institution_ids":["https://openalex.org/I4387153259"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002922217","display_name":"Jeffrey Alan Silverman","orcid":"https://orcid.org/0009-0001-3208-016X","observed_orcids":["https://orcid.org/0009-0001-3208-016X"]},"institutions":[{"id":"https://openalex.org/I4387153259","display_name":"Edgewise Therapeutics (United States)","ror":"https://ror.org/03phcd550","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153259"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey A. Silverman","raw_affiliation_strings":["Edgewise Therapeutics, Inc.  Boulder Colorado USA"],"raw_orcid":"https://orcid.org/0009-0001-3208-016X","affiliations":[{"raw_affiliation_string":"Edgewise Therapeutics, Inc.  Boulder Colorado USA","institution_ids":["https://openalex.org/I4387153259"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5002922217"],"corresponding_institution_ids":["https://openalex.org/I4387153259"],"apc_list":{"value":3630,"currency":"USD","value_usd":3630},"apc_paid":{"value":3630,"currency":"USD","value_usd":3630},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82965231,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"11","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9380000233650208},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.7730000019073486},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8640000224113464},{"id":"https://openalex.org/keywords/cyp3a4-inhibition","display_name":"CYP3A4 inhibition","score":0.8999999761581421},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.996999979019165},{"id":"https://openalex.org/keywords/high-fat-meal","display_name":"high-fat meal","score":0.777999997138977},{"id":"https://openalex.org/keywords/becker-muscular-dystrophy","display_name":"Becker muscular dystrophy","score":0.9200000166893005},{"id":"https://openalex.org/keywords/duchenne-muscular-dystrophy","display_name":"Duchenne muscular dystrophy","score":0.9929999709129333}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8700000047683716},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.8116999864578247},{"id":"https://openalex.org/C11824378","wikidata":"https://www.wikidata.org/wiki/Q5014970","display_name":"CYP3A","level":4,"score":0.7439000010490417},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6930000185966492},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.629800021648407},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.5206000208854675},{"id":"https://openalex.org/C2992379925","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Pharmacokinetic interaction","level":4,"score":0.46790000796318054},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4368000030517578},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4138999879360199},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4058000147342682},{"id":"https://openalex.org/C2778345441","wikidata":"https://www.wikidata.org/wiki/Q6460735","display_name":"Meal","level":2,"score":0.3978999853134155},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.39070001244544983},{"id":"https://openalex.org/C79410662","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Dose\u2013response relationship","level":2,"score":0.37439998984336853},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.3479999899864197},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3278999924659729},{"id":"https://openalex.org/C3018685816","wikidata":"https://www.wikidata.org/wiki/Q213449","display_name":"Food intake","level":2,"score":0.3246999979019165},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3222000002861023},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.3212999999523163},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32019999623298645},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.2994999885559082},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.29760000109672546},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.29249998927116394},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.2883000075817108},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.27399998903274536},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.26660001277923584},{"id":"https://openalex.org/C99476002","wikidata":"https://www.wikidata.org/wiki/Q42297","display_name":"Analysis of variance","level":2,"score":0.26159998774528503},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.2574999928474426},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.25220000743865967},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.25029999017715454}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018565","descriptor_name":"Food-Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064368","descriptor_name":"Healthy Volunteers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065692","descriptor_name":"Cytochrome P-450 CYP3A Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D065692","descriptor_name":"Cytochrome P-450 CYP3A Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/cts.70751","doi":"https://doi.org/10.1111/cts.70751","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.70751","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70751","source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13729000","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13729000/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13729000/pdf/CTS-19-e70751.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Transl Sci","raw_type":"Text"},{"id":"pmid:42974700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42974700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and translational science","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/cts.70751","doi":"https://doi.org/10.1111/cts.70751","is_oa":true,"landing_page_url":"https://doi.org/10.1111/cts.70751","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70751","source":{"id":"https://openalex.org/S106654227","display_name":"Clinical and Translational Science","issn_l":"1752-8054","issn":["1752-8054","1752-8062"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Translational Science","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225160844.pdf","grobid_xml":"https://content.openalex.org/works/W7225160844.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1850477203","https://openalex.org/W2001548627","https://openalex.org/W2109050641","https://openalex.org/W2140969193","https://openalex.org/W2324520843","https://openalex.org/W4361269714","https://openalex.org/W4382069925","https://openalex.org/W4410966848","https://openalex.org/W7165036778","https://openalex.org/W7167252366"],"related_works":["https://openalex.org/W7167252366","https://openalex.org/W2274010551","https://openalex.org/W4409822087","https://openalex.org/W2894958559","https://openalex.org/W582200134","https://openalex.org/W4213240356","https://openalex.org/W4394611646","https://openalex.org/W2750441724","https://openalex.org/W2916421989","https://openalex.org/W3152050242"],"abstract_inverted_index":{"ABSTRACT":[0],"Sevasemten":[1],"(EDG\u20105506)":[2],"is":[3,24],"an":[4],"investigational,":[5],"small":[6],"molecule,":[7],"in":[8],"development":[9],"for":[10,27],"the":[11,35,57,105,114,141,166,175],"treatment":[12],"of":[13,38,52,59,70,89,93,98,119,126,134,143,156,160,168,208],"Becker":[14],"and":[15,83,136,205],"Duchenne":[16],"muscular":[17],"dystrophy.":[18],"In":[19],"vitro":[20],"data":[21,187],"suggest":[22],"sevasemten":[23,39,60,79,84,94,120,127,144,161,169,194,209],"a":[25,45,53,90,123,151,157,198],"substrate":[26],"cytochrome":[28],"P450":[29],"(CYP)3A4.":[30],"Here,":[31],"we":[32],"investigate":[33],"whether":[34],"pharmacokinetics":[36],"(PK)":[37],"are":[40],"affected":[41],"when":[42],"co\u2010administered":[43,80],"with":[44,81,95],"moderate":[46,152,199],"CYP3A4":[47,153],"inhibitor,":[48],"verapamil.":[49],"The":[50],"impact":[51],"high\u2010fat":[54],"meal":[55],"on":[56,104],"PK":[58,142],"was":[61],"also":[62,196],"investigated.":[63],"This":[64],"Phase":[65],"1,":[66],"open\u2010label,":[67],"parallel":[68],"study":[69],"healthy":[71],"subjects":[72],"dosed":[73],"three":[74],"unique":[75],"cohorts":[76],"(sevasemten":[77],"alone,":[78],"verapamil,":[82,150],"under":[85,113,128,162,182],"fed":[86,163],"conditions).":[87],"Administration":[88,155],"single":[91,124,158],"dose":[92,125,159,203],"daily":[96],"dosing":[97],"verapamil":[99],"had":[100],"no":[101],"significant":[102],"effect":[103],"maximum":[106],"concentration":[107],"(C":[108],"max":[109,177],")":[110],"or":[111],"area":[112],"plasma":[115],"concentration\u2010time":[116],"curve":[117],"(AUC)":[118],"compared":[121],"to":[122,172,180,195,212],"fasted":[129,183],"conditions":[130,164],"(Geometric":[131],"mean":[132],"ratios":[133],"101.6%":[135],"97.5%,":[137],"respectively),":[138],"indicating":[139],"that":[140,181],"may":[145],"not":[146],"be":[147],"influenced":[148],"by":[149,170],"inhibitor.":[154],"increased":[165],"AUCs":[167],"20%":[171],"38%,":[173],"while":[174],"C":[176],"remained":[178],"comparable":[179],"conditions.":[184],"Together,":[185],"these":[186],"support":[188,206],"allowing":[189],"patients":[190],"who":[191],"benefit":[192],"from":[193],"use":[197],"CYP3A":[200],"inhibitor":[201],"without":[202,210],"modification":[204],"administration":[207],"regard":[211],"food":[213],"intake.":[214]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-11-04T00:00:00"}